Table 3. Overall and Disease-Specific Survival (N = 1207).
| Characteristic | Overall Survival | Disease-Specific Survival | ||||
| 2 Year, % (95% CI) | 5 Year, % (95% CI) | 10 Year, % (95% CI) | 2 Year, % (95% CI) | 5 Year, % (95% CI) | 10 Year, % (95% CI) | |
| All | 46.8 (43.8 to 49.8) | 32.9 (29.8 to 36.0) | 21.9 (18.2 to 25.9) | 56.1 (52.9 to 59.1) | 44.0 (40.5 to 47.5) | 35.9 (31.3 to 40.5) |
| Age, years | ||||||
| 50 or less | 67.0 (58.9 to 73.9) | 57.5 (48.7 to 65.3) | 47.6 (36.7 to 57.7) | 74.4 (66.3 to 80.9) | 64.6 (55.4 to 72.4) | 58.6 (47.8 to 68.0) |
| 51–60 | 54.5 (47.5 to 60.9) | 38.8 (31.3 to 46.2) | 31.0 (22.2 to 40.3) | 62.7 (55.5 to 69.0) | 48.4 (40.1 to 56.2) | 40.7 (30.0 to 51.2) |
| 61–70 | 52.7 (45.9 to 59.1) | 39.6 (32.5 to 46.6) | 19.5 (11.2 to 29.5) | 57.4 (50.5 to 63.8) | 46.7 (39.2 to 53.9) | 31.5 (21.3 to 42.3) |
| 71–80 | 39.7 (34.4 to 45.0) | 22.9 (18.0 to 28.2) | 12.5 (7.6 to 18.7) | 49.8 (43.9 to 55.3) | 35.9 (29.6 to 42.3) | 30.3 (22.4 to 38.6) |
| 81 or more | 25.1 (18.8 to 31.7) | 14.4 (9.0 to 21.0) | 12.3 (6.9 to 19.5) | 40.6 (32.2 to 48.8) | 29.9 (21.3 to 39.0) | 25.6 (15.6 to 36.9) |
| Sex | ||||||
| Male | 44.1 (40.0 to 48.2) | 28.1 (24.0 to 32.3) | 19.3 (14.8 to 24.3) | 54.2 (49.8 to 58.5) | 40.7 (35.8 to 45.5) | 32.0 (25.8 to 38.3) |
| Female | 49.7 (45.4 to 53.9) | 38.3 (33.7 to 42.9) | 24.9 (18.9 to 31.4) | 58.0 (53.5 to 62.3) | 47.6 (42.5 to 52.5) | 40.6 (34.0 to 47.1) |
| Race | ||||||
| White | 47.6 (44.2 to 50.8) | 33.2 (29.7 to 36.7) | 22.4 (18.2 to 26.9) | 56.9 (53.4 to 60.2) | 44.0 (40.1 to 47.9) | 35.8 (30.6 to 41.0) |
| Other | 43.7 (36.9 to 50.3) | 31.4 (24.6 to 38.4) | 19.8 (12.4 to 28.6) | 52.7 (45.4 to 59.6) | 43.9 (35.9 to 51.6) | 36.0 (25.8 to 46.3) |
| Stage | ||||||
| I | 50.5 (40.1 to 60.0) | 43.7 (33.3 to 53.6) | 34.7 (22.6 to 47.0) | 66.0 (54.8 to 75.0) | 62.4 (50.7 to 72.0) | 56.1 (39.8 to 69.6) |
| II | 63.3 (52.3 to 72.4) | 39.5 (27.6 to 51.2) | 24.7 (10.7 to 41.7) | 76.5 (65.5 to 84.4) | 56.8 (43.1 to 68.4) | 47.3 (26.8 to 65.4) |
| III | 45.5 (40.9 to 50.0) | 32.5 (27.8 to 37.4) | 23.0 (17.6 to 28.8) | 54.4 (49.5 to 59.1) | 44.1 (38.7 to 49.4) | 35.1 (28.0 to 42.2) |
| IV | 42.2 (37.3 to 47.1) | 28.3 (23.5 to 33.3) | 18.7 (13.2 to 25.0) | 49.1 (43.8 to 54.1) | 36.3 (30.7 to 41.8) | 30.2 (23.3 to 37.4) |
| Unstaged | 60.1 (44.8 to 72.5) | 40.1 (25.0 to 54.8) | 16.7 (4.1 to 36.7) | 74.8 (58.9 to 85.3) | 52.5 (33.9 to 68.2) | 39.4 (19.6 to 58.7) |
| Year of diagnosis | ||||||
| 1992–1998 | 44.6 (34.7 to 53.9) | 28.7 (20.3 to 37.7) | 15.8 (9.5 to 23.6) | 53.1 (42.5 to 62.7) | 41.7 (31.2 to 51.8) | 25.4 (16.2 to 35.6) |
| 1999–2001 | 51.2 (42.2 to 59.5) | 35.4 (27.2 to 43.7) | 26.0 (18.7 to 33.8) | 60.4 (50.8 to 68.7) | 46.7 (37.2 to 55.8) | 43.3 (33.7 to 52.5) |
| 2002–2004 | 42.7 (36.4 to 48.9) | 27.8 (22.3 to 33.6) | NR | 55.2 (48.3 to 61.5) | 41.6 (34.7 to 48.4) | NR |
| 2005–2007 | 48.9 (43.4 to 54.2) | 37.7 (31.9 to 43.6) | NR | 59.1 (53.2 to 64.5) | 48.5 (41.9 to 54.8) | NR |
| 2008–2010 | 45.1 (38.8 to 51.2) | NR | NR | 51.2 (44.6 to 57.4) | NR | NR |
Abbreviations: NR, not reached.